Ekso Bionics Holdings, Inc. is a leading developer of exoskeleton solutions designed to enhance human strength, endurance, ...

Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products that augment human strength, endurance, and mobility. The primary end market for our exoskeleton technology is ...

Ekso Bionics Holdings, Inc., a leader in exoskeleton technology, reported strong financial results for the fourth quarter and full year ended December 31, 2024. The company achieved a record ...

The robotic exoskeleton company posted revenue of $5.1 million in the period. SAN RAFAEL, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics ...

(“Ekso Bionics” or the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three and twelve months ended ...

Feb. 24, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that ...

(AP) — Ekso Bionics Holdings Inc. (EKSO ... based company said it had a loss of 14 cents per share. The robotic exoskeleton company posted revenue of $5.1 million in the period.

Historically, the technology has been used medically for rehabilitation. Now, however, exoskeleton are used recreationally ...

StockNews.com started coverage on shares of Ekso Bionics (NASDAQ:EKSO – Free Report) in a research report report published on Sunday morning. The brokerage issued a hold rating on the stock.

Ekso Bionics Holdings, Inc. engages in the design, development and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. It operates through the ...

Shares of NASDAQ:EKSO opened at $0.38 on Friday. The company has a market cap of $9.38 million, a PE ratio of -0.58 and a beta of 1.33. The company’s 50 day moving average is $0.50 and its two ...